Satsuma Pharmaceuticals Inc (STSA) Stock
STSA is no longer traded. Satsuma Pharmaceuticals was delisted from the Nasdaq in June 2023.
Prices on this page are historical; the last trade was June 7, 2023 at $1.10.
Satsuma Pharmaceuticals stock price history
STSA final trading statistics
- Final close
- $1.10
- Final trading day
- Jun 7, 2023
- Market cap at delisting
- $36.47M
- Shares outstanding
- 33.15M
- Final 52-week range
- $0.59 – $8.08
- Avg. volume (final 3 mo.)
- 1,102,202
- All-time high (split-adj.)
- $34.69 · Jun 2020
- All-time low (split-adj.)
- $0.61 · Nov 2022
- Return since IPO
- -93.5%
- Beta
- 0.10
- Book value / share
- $1.14
- Price / book
- 0.97
Satsuma Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$69.2M | -$2.19 |
| FY2021 | $0.00 | -$51.2M | -$1.77 |
| FY2020 | $0.00 | -$47.3M | -$2.74 |
| FY2019 | $0.00 | -$28.0M | -$3.34 |
| FY2018 | $0.00 | -$7.3M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Satsuma Pharmaceuticals Inc
Satsuma Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops novel therapeutic products for the acute treatment of migraines. The company's product candidature includes STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. As of June 8, 2023, Satsuma Pharmaceuticals, Inc. operates as a subsidiary of Shin Nippon Biomedical Laboratories, Ltd.
Satsuma Pharmaceuticals stock FAQ
What happened to Satsuma Pharmaceuticals stock?
Satsuma Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $1.10 on June 7, 2023.
Is STSA stock still trading?
No. STSA was delisted from the Nasdaq in June 2023 and no longer trades on a U.S. exchange.
What was the last price of STSA stock?
STSA closed at $1.10 on its final trading day, June 7, 2023, for a market value of about $36.47M.
What were Satsuma Pharmaceuticals's revenue and earnings in its last full fiscal year?
Satsuma Pharmaceuticals reported revenue of $0.00 and net income of -$69.2M in fiscal 2022, its last full year as a public company.
When did Satsuma Pharmaceuticals go public?
Satsuma Pharmaceuticals Inc stock began trading on September 13, 2019.